A randomised, double-blind trial of Valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced Human Immunodeficiency Virus Infection.

The ACTG 204 /Glaxo Wellcome 1230-014 International CMV Prophylaxis Study Group

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)48-56.
Number of pages9
JournalJournal Infectious Diseases
Volume177
Publication statusPublished - 1998

Cite this